ArticleActa pharmacologica Sinica2021

Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.